Product
Utidelone + Anlotinib
1 clinical trial
1 indication
Indication
Esophageal cancerClinical trial
A Multicenter, Single-arm, Exploratory Clinical Study of Utidelone Combined With Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer That Has Failed Standard First-line TherapyStatus: Recruiting, Estimated PCD: 2024-04-30